Table 1.

Patient Characterization in the Blinded Clinical Evaluation Study for the MEBGEN RASKET-B KIT

		Total (N = 302)
Age, years	Median (minimum-maximum)	64 (26-89)
Sex	Male	178
	Female	124
Primary tumor location	Right-sided colon*	62
	Left-sided colon†	98
	Rectum‡	142
Stage	Stage 0-I	33
	Stage II	48
	Stage III	125
	Stage IV	96
Histologic type	Well to moderately differentiated adenocarcinoma	273
	Poorly differentiated or mucinous	29
Tumor area ratio (%)	Median (minimum-maximum)	50 (5-100)
Tumor cell ratio (%)	Median (minimum-maximum)	50 (5-90)

^*Cecum, ascending colon, and transverse colon.

^†Descending colon and sigmoid colon.

^‡Rectum (Ra, and Rb). Ra: upper rectum (above peritoneal reflection), Rb: lower rectum (below peritoneal reflection).